Fmoc-4-Trifluoromethyl-L-Phenylalanine

Fmoc-4-Trifluoromethyl-L-Phenylalanine is an Fmoc-protected L-phenylalanine derivative bearing a para-trifluoromethyl substituent on the aromatic ring, creating a chiral amino acid building block with enhanced lipophilicity and strong electron-withdrawing character. The molecule contains an Fmoc carbamate on the α-amino group and a free or activatable carboxyl functionality depending on the supplier form, enabling controlled peptide coupling while maintaining stereochemical integrity at the L-center. The 4-CF3 phenyl side chain provides a fluorinated aromatic handle that can influence conformational preferences and metabolic stability in peptide analogs and peptidomimetics. The combination of a stable N-protecting group and a chemically robust aromatic CF3 motif makes the compound suitable as a protected amino acid intermediate for downstream synthetic diversification.

1. Peptide Synthesis

Fmoc-4-Trifluoromethyl-L-Phenylalanine is used in peptide synthesis workflows where Fmoc protection supports stepwise solid-phase or solution-phase coupling. The Fmoc carbamate allows orthogonal deprotection under standard base conditions, while the L-configuration at the α-carbon helps preserve stereochemical fidelity during amide bond formation. The para-trifluoromethyl phenyl side chain participates as a nonpolar aromatic substituent that can modulate local hydrophobicity and packing in peptide sequences. The resulting CF3-bearing peptide products can serve as structure-defined reagents for biochemical assays, peptide library generation, and peptidomimetic scaffold construction in medicinal chemistry research.

2. Peptidomimetics And SAR Studies

Fmoc-4-Trifluoromethyl-L-Phenylalanine is applied to peptidomimetic and structure-activity relationship studies that require fluorinated aromatic substitutions. The CF3-substituted phenyl group provides a distinct steric and electronic profile compared with unsubstituted phenylalanine, supporting systematic SAR mapping of hydrophobic and electron-withdrawing effects. The protected amino acid form enables incorporation into analogs through peptide coupling chemistry, generating amide-linked CF3 aromatic motifs at defined positions within a scaffold. The produced analogs can be used as chemically characterized intermediates for SAR-driven optimization of binding-site interactions and for comparative studies across closely related amino acid substitutions.

3. Chemical Biology Labeling

Fmoc-4-Trifluoromethyl-L-Phenylalanine supports chemical biology labeling strategies where defined aromatic fluorinated residues are incorporated into peptides or protein fragments. The Fmoc group enables controlled incorporation during peptide assembly, and the resulting CF3-bearing aromatic side chain can function as a stable tag that withstands many derivatization and purification conditions. The amino acid's carboxyl/amine functionality pattern is compatible with standard peptide coupling to generate conjugatable peptide intermediates for downstream functionalization. The CF3 motif can also be leveraged for analytical traceability in labeling workflows and for constructing molecular probes that maintain structural resemblance to native peptide contexts.

4. Chiral Building Block Development

Fmoc-4-Trifluoromethyl-L-Phenylalanine is suitable as a chiral amino acid intermediate for asymmetric or stereocontrolled synthetic sequences that require an L-phenylalanine framework. The molecule's preserved L-stereocenter, combined with the orthogonally removable Fmoc protecting group, supports its use as a stereochemically defined building block in multistep derivatization. The para-CF3 aromatic substituent provides a chemically stable stereochemical "reporter" region that can be carried through to final compounds without rapid side-chain modification. The compound can therefore be employed to prepare stereodefined fluorinated analogs used in synthetic methodology development and in the synthesis of chiral libraries for medicinal chemistry and materials-oriented research.

5. Pharmaceutical Intermediate Preparation

Fmoc-4-Trifluoromethyl-L-Phenylalanine is utilized in pharmaceutical intermediate preparation where fluorinated amino acid residues are incorporated into peptide-like intermediates for downstream manufacturing. The Fmoc-protected α-amino group enables reliable peptide coupling chemistry to build amide-rich intermediates under controlled protection-deprotection cycles. The CF3-substituted aromatic side chain can serve as a structural element in processable intermediates that require improved chemical robustness and altered physicochemical properties relative to non-fluorinated analogs. The resulting CF3-containing peptide intermediates can be carried forward into further functional group transformations, purification development, and final API-adjacent synthesis planning within industrial fine chemical production.

6. Process Chemistry Intermediate

Fmoc-4-Trifluoromethyl-L-Phenylalanine is relevant to process chemistry for manufacturing routes that prioritize protected amino acid stability and predictable coupling behavior. The Fmoc carbamate provides a well-defined protection strategy for the α-amino group, supporting reproducible deprotection and coupling operations during scale-up of peptide building blocks. The aromatic CF3 substituent is chemically resistant and can endure common synthetic conditions used in intermediate preparation, enabling consistent incorporation into larger target molecules. The compound thus functions as a practical chiral intermediate for industrial synthesis of fluorinated peptide analogs and peptidomimetic fragments, where downstream transformations depend on maintaining stereochemical and functional-group integrity.

1. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

2. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

3. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

4. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

5. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII